Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics

Br J Pharmacol. 2018 Dec;175(23):4285-4294. doi: 10.1111/bph.14511. Epub 2018 Nov 8.

Abstract

Retinoids, vitamin A and its natural and synthetic analogues have various functions, including being involved in cell proliferation and differentiation and participating in the formation of vertebrate morphology. In addition, they may activate certain tumour suppressor genes that then act as tumour inhibitors. In the past decades, retinoids have been regarded as promising chemotherapeutic and chemopreventive agents; however, their mechanisms are still not fully understood. Immune cells that participate in or are associated with the immune response play vital roles in the initiation and development of many cancers. Interestingly, recent studies have demonstrated that retinoids can also exert various effects on immune cells including macrophages, T cells and dendritic cells in tumour tissues to execute anti-tumour actions, providing new insights into chemoprevention and chemotherapeutics. In this review, we focus on the effects of retinoids on immune cells in the tumour, which may provide new approaches for antineoplastic strategies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • Humans
  • Macrophages / drug effects
  • Macrophages / immunology
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neoplasms / prevention & control
  • Retinoids / pharmacology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Antineoplastic Agents
  • Retinoids